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Abstract
Background: The genome of herpes simplex virus 1 encodes at least 84 transcripts from which proteins are translated 
and several additional RNAs whose status as mRNAs is unknown. These RNAs include latency-associated transcript, 
OriS1 and OriS2 RNAs and in case of α4 null mutant additional transcript that spans the junction between L and S 
component of the HSV-1 genome. Current data do not suggest that a peptide is translated from these RNAs.
Results: We describe here a novel RNA designated US5-1 that spans 4.5 kb of the unique-short (US) region. The RNA 
initiates in US5 and terminates in the α22 open reading frame. It is expressed antisense to US5, US4, US3 and ICP22 
mRNAs. This transcript is expressed with γ2 kinetics and has a half-life of 80 minutes.
Conclusion: These results identify a novel transcript encoded within HSV-1 genome. Since no major hypothetical 
open-reading frames are present in this transcript it is feasible that this RNA exerts its function as a non-coding RNA.
Background
The original report of the organization of the unique
short (US) DNA sequences of the herpes simplex virus 1
(HSV-1) listed 12 open reading frames (ORFs) designated
US1 (α22) through US12 (α47) [1]. Subsequent studies led
to the discovery of three additional transcripts and at
least two non coding transcripts. The coding transcripts
were US8.5 mRNA co-terminal with US8 and US9 [2],
US1.5 co-terminal with the α22 transcript [3], and US3.5
co-terminal with the US3 mRNA [4]. The non coding
transcript OriS1 initiated in α22 or α47 ORFs, run across
the origins of DNA synthesis and terminated at the tran-
scription termination site of the α4 gene. OriS2 termi-
nated at or near the transcription initiation site of the α22
or α47 gene [5]. Latency-associated transcript (LAT) is
the only viral transcript detected in latently infected neu-
rons [6]. Although several potential ORFs can be found
within LAT sequence, none of them are transcribed in
the context of viral infection [7,8]. In addition, Schaffer
and colleagues [9] reported transcripts in cells infected
with Δα4 mutant that spanned the junction between the
L and S components of HSV-1 DNA. While it is sus-
pected that LAT plays a role in the establishment and
maintenance of latent infection, its function is not well
established. Also, the roles of OriS transcripts or Δα4-spe-
cific transcript are unknown. In this report we describe
an additional long transcript designated US5-1 RNA. As
the designation implies, this transcript originates in the
US5 ORF and terminates in the α22 ORF.
Results
RNA antisense to US3 is expressed in cells infected with 
wild-type virus
The experiments reported here resulted from the obser-
vation that a mutant derived from R7208 contained an
unexplained 1.6 kb RNA antisense to the US3 ORF.
Briefly, in this mutant the α22 gene was deleted and in the
course of studies of a selected isolate of this mutant we
found that it contained an insertion containing a stop
codon upstream of the US3 ORF. To determine whether
RNA antisense to US3 is expressed in cells infected with
wild-type virus, rabbit skin cells (RSC) were exposed to
10 PFU of HSV-1(F) per cell, RNA was extracted 18 h
later and subjected to RT-PCR or Northern blot analysis.
* Correspondence: bernard.roizman@bsd.uchicago.edu
1 The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, 
Chicago IL 60637, USA
Full list of author information is available at the end of the articleJovasevic and Roizman Virology Journal 2010, 7:103
http://www.virologyj.com/content/7/1/103
Page 2 of 8
For RT-PCR analysis cDNA was generated from total
RNA using primer 51(R), specific for RNAs antisense to
US3. PCR reaction was performed using the 51(F) as for-
ward and 51(R) as reverse primer. While reverse tran-
scription with 51(R) primer would also generate cDNA
from US2 transcript, this cDNA would not be amplified
under PCR reaction used in this experiment since 51(F)
primer lies upstream from US2 transcript (Fig. 1C).
Results of RT-PCR analysis (Fig. 2A) show that antisense
RNA was also expressed in cells infected with wild-type
virus. Northern blot analysis, performed using 1% aga-
rose gel, (Fig. 2B) verified these results and additionally
indicated that in cells infected with the wild type virus the
RNA was approximately 4.5 kb long.
The US5-1 transcript spans genomic region between US5 
and α22
Experiments were next carried out to determine the
region of the S component spanned by the US5-1 mRNA.
To determine the location of the 5'-end we relied initially
on observations carried out on the R7802 recombinant
virus. In cells infected with this mutant, the truncated
US5-1 RNA terminated at the polyadenylation signal
inserted into the US2/US3 boundary (V. Jovasevic. and B.
Roizman, manuscript in preparation). Knowing the size
of this RNA (~1.6 kb), we estimated the location of its 5'-
end on the basis of the assumption that the sequences
upstream of the insertion site would be identical in both
R7802 and wild-type virus. In order to fine map the loca-
tion of the 5'-end of the US5-1 transcript, we performed a
series of northern blot analyses that helped us place the
5'-end within the sequences covered by the probe 3 (data
not shown). To determine more precisely the location of
the 5'-end of the US5-1 transcript we performed an
RNase-protection assay using probe 3. The results of this
experiment reveal the presence of a protected fragment
with size of about 270 bases (Fig. 3A, arrow). In figure 1A
the sequence of the probe 3 is shown in red and under-
lined are the first 270 bases of the probe 3 protected in
the RNase protection assay. A potential TATA box
sequence can be observed upstream from the last under-
lined base (boxed sequence), making it more likely that
the underlined sequence of the probe 3 is the 5' terminus
of the US5-1 transcript.
On the basis of the size of the US5-1 transcript and the
location of its 5'-end we estimated the location of the 3'-
end to be within the ICP22 ORF. To determine more pre-
cisely the location of the 3'-end, RSC were infected with
10 PFU of HSV-1(F) per cell, RNA extracted 18 h later
and subjected to RNase protection assay using a probe
that spanned the predicted termination site identified
within ICP22 ORF (probe 1). The probe 1 protected frag-
ment of approximately 180 bases long (Fig. 3B, arrow). In
figure 1B the sequence of the probe 1 is shown in red and
underlined are the last 180 bases of the probe 1 protected
in the RNase protection assay. In the vicinity of the iden-
tified 3'-end we observed a sequence that could poten-
tially serve as a polyadenylation sequence for the US5-1
transcript (boxed sequence). In addition to the 180 bases
long fragment we also observed another protected frag-
ment that was equal in length to the full-length probe.
This fragment does not correspond to the U S5-1 tran-
script, considering that the US5-1 transcript is ~4.5 kb
long. It is possible that a different RNA, expressed anti-
sense to ICP22, is present in infected cells.
Figure 1C illustrates schematically the domains of tran-
scripts mapped in the S component to date. Single-
stranded RNA probes used for Northern blot and RNase
protection assay are represented by green arrows. Prim-
ers used for RT-PCR analysis are represented by blue
arrowheads.
The US5-1 transcript is expressed with γ2 kinetics
In the experiments described next, we evaluated the tim-
ing and requirements for the expression of the US5-1
RNA. In the first series of experiments, RSC were
exposed to 10 PFU of HSV-1(F) per cell, RNA extracted 1,
3, 6, or 9 h later and subjected to northern blot analysis
using probe 2 for detection of the US5-1 transcript. The
results (figure 4A) show that the US5-1 could not be
detected at 1 or 3 h after infection. It was first detected at
6 h after infection.
In the next series of experiments we determined
whether the onset of synthesis of US5-1 requires de novo
viral protein synthesis. RSC were infected with 10 PFU of
HSV-1(F) per cell in the presence or absence of 100 μg/ml
cycloheximide. Total RNA was extracted 9 h later and
subjected to northern blot analysis. Addition of cyclohex-
imide completely abrogated the expression of the US5-1
transcript (Fig. 4B), indicating that de novo protein syn-
thesis is essential for its expression.
The purpose of the next series of experiments was to
determine whether viral DNA synthesis was required for
the synthesis of US5-1 RNA. RSC were exposed to 10 PFU
of HSV-1(F) per cell in the presence or absence of 300 μg
of PAA per ml. Total RNA was extracted 9 h later and
subjected to northern blot analysis. PAA completely
abrogated the expression of the US5-1 transcript (Fig.
4C), indicating that the replication of viral DNA is essen-
tial for its expression, and therefore that the US5-1 tran-
script is expressed with γ kinetics. Since the expression of
the RNA was completely abrogated in the presence of
PAA and not just diminished we conclude that the US5-1
transcript is expressed with γ2kinetics.Jovasevic and Roizman Virology Journal 2010, 7:103
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Figure 1 Genomic location of the US5-1 RNA. (A) In red is shown the sequence of the probe 3, used for the determination of the 5'-end of the US5-
1 RNA. Underlined are first 270 bases of the probe 3, which was the size of the protected fragment in the RNase protection experiment to determine 
the 5'-end of the US5-1 RNA. In the box is the sequence of potential TATA box. (B) In red is shown the sequence of the probe 1, used for the determi-
nation of the 3'-end of the US5-1 RNA. Underlined are the last 180 bases of the probe 1, which was the size of the protected fragment. Sequence of a 
possible polyadenylation signal for the US5-1 transcript is shown in the box. (C) Location and the direction of transcription of RNAs expressed from 
the unique-short region are represented by arrows. Red arrows represent protein-coding RNAs, black arrows represent non-coding RNAs. Location 
and the direction of the transcription of the single-stranded RNA probes used in the experiments described in this report are represented by green 
arrows. Primers used for RT-PCR detection of US5-1 transcript are shown in blue arrowheads.
137701 AGCACACGAC TTGGCGTTCT GTGTGTCGCG ATGTCTCTGC GCGCAGTCTG GCATCTGGGG
A
137701 AGCACACGAC TTGGCGTTCT GTGTGTCGCG ATGTCTCTGC GCGCAGTCTG GCATCTGGGG
137761 CTTTTGGGAA GCCTCGTGGG GGCTGTTCTT GCCGCCACCC ATCGGGGACC TGCGGCCAAC
137821 ACAACGGACC CCTTAACGCA CGCCCCAGTG TCCCCTCACC CCAGCCCCCT GGGGGGCTTT
137881 GCCGTCCCCC TCGTAGTCGG TGGGCTGTGC GCCGTAGTCC TGGGGGCGGC ATGTCTGCTT
137941 GAGCTCCTGC GTCGTACGTG CCGCGGGTGG GGGCGTTACC ATCCCTACAT GGACCCAGTT
138001 GTCGTATAAT TTCCCCCCCC CCCCCCCTTC TCCGCGTGGG TGATGTCGGG TCCAAACTCC
138061 CGACACCACC AGCTGGCATG GTATAAATCA CCGGTGCGCC CCCCAAACCA TGTCCGGCAG
138121 GGGGATGGGG GGGCAATGCG GAGGGCACCC AACAACACCG GGCTAACCAG GAAATCCGTG
132601 CGGGCGGGGG GAAGCCACTG TGGTCCTCCG GGACGTTTTC TGGATGGCCG ACATTTCCCC
132661 AGGCGCTTTT GCGCCTTGTG TAAAAGCGCG GCGTCCCGCT CTCCGATCCC CGCCCCTGGG
132721 CACGCGCAAG CGCAAGCGCC CTTCCCGCCC CCTCTCATCG GAGTCTGAGG TAGAATCCGA
132781 TACAGCCTTG GAGTCTGAGG TCGAATCCGA GACAGCATCG GATTCGACCG AGTCTGGGGA
132841 CCAGGATGAA GCCCCCCGCA TCGGTGGCCG TAGGGCCCCC CGGAGGCTTG GGGGGCGGTT
132901 TTTTCTGGAC ATGTCGGCGG AATCCACCAC GGGGACGGAA ACGGATGCGT CGGTGTCGGA
B
132901 TTTTCTGGAC ATGTCGGCGG AATCCACCAC GGGGACGGAA ACGGATGCGT CGGTGTCGGA
132961 CGACCCCGAC GACACGTCCG ACTGGTCTTA TGACGACATT CCCCCACGAC CCAAGCGGGC
133021 CCGGGTAAAC CTGCGGCTCA CGAGCTCTCC CGATCGGCGG GATGGGGTTA TTTTTCCTAA
133081 GATGGGGCGG GTCCGGTCTA CCCGGGAAAC GCAGCCCCGG GCCCCCACCC CGTCGGCCCC
133141 AAGCCCAAAT GCAATGCTAC GGCGCTCGGT GCGCCAGGCC CAGAGGCGGA GCAGCGCACG
133201 ATGGACCCCC GACCTGGGCT ACATGCGCCA GTGTATCAAT CAGCTGTTTC GGGTCCTGCG
133261 GGTCGCCCGG GACCCCCACG GCAGTGCCAA CCGCCTGCGC CACCTGATAC GCGACTGTTA
133321 CCTGATGGGA TACTGCCGAG CCCGTCTGGC CCCGCGCACG TGGTGCCGTT TGCTGCAGGT
133381 GTCCGGCGGA ACCTGGGGCA TGCACCTGCG CAACACCATA CGGGAGGTGG AGGCTCGATT
133441 CGACGCCACC GCGGAACCCG TGTGCAAGCT TCCTTGTTTG GAGACCAGAC GGTACGGCCC
133501 GGAGTGTGAT CTTAGTAATC TCGAGATTCA TCTCAGCGCG ACAAGCGATG ATGAAATCTC
133561 CGATGCCACC GATCTGGAGG CCGCCGGTTC GGACCACACG CTCGCGTCCC AGTCCGACAC
133621 GGAGGATGCC CCCTCCCCCG TTACGCTGGA AACCCCAGAA CCCCGCGGGT CCCTCGCTGT
133681 GCGTCTGGAG GATGAGTTTG GGGAGTTTGA CTGGACCCCC CAGGAGGGCT CCCAGCCCTG
133741 GCTGTCTGCG GTCGTGGCCG ATACCAGCTC CGTGGAACGC CCGGGCCCAT CCGATTCTGG
133801 GGCGGGTCGC GCCGCAGAAG ACCGCAAGTG TCTGGACGGC TGCCGGAAAA TGCGCTTCTC 133801 GGCGGGTCGC GCCGCAGAAG ACCGCAAGTG TCTGGACGGC TGCCGGAAAA TGCGCTTCTC
133861 CACCGCCTGC CCCTATCCGT GCAGCGACAC GTTTCTCCGG CCGTGAGTCC GGTCGCCCCG
133921 ACCCCCTTGT ATGTCCCCAA AATAAAAGAC CAAAATCAAA GCGTTTGTCC CAGCGTCTTA
133981 ATGGCGGGAA GGGCGGAGAG AAACAGACCA CGCGGACATG GGGGGTGTTT GGGGGTTTAT
134041 TGGCACCGGG GGCTAAAGGG TGGTAACCGG ATAGCAGATG TGAGGAAGTC GGGGCCGTTC
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The US5-1 transcript has a half-life of about 80 minutes
In the final set of experiments we proceeded to evaluate
the stability of the US5-1 transcript. RSC were infected
with 10 PFU of HSV-1(F) per cell. At 6 h after infection
the cells were exposed to 100 μg of actinomycin D per ml
of medium. The RNA was extracted at 0, 1, 2, 3 or 4 h
after the addition of the actinomycin D and subjected to
northern blot analysis (Fig. 4D). The intensity of individ-
ual bands was measured by a densitometer and plotted as
a function of time (Fig. 4E). The results shown in figure
4E indicate that the half-life of the US5-1 transcript was
approximately 80 min.
Discussion
Relevant to this report are the following:
(i) One possible explanation for the failure to detect the
4.5 kb RNA in earlier studies is the failure of transfer of
high molecular weight RNA from gels containing high
concentrations of agarose. In the studies reported here,
we detected the 4.5 kb RNA on transfer from gels con-
taining 1%, or less, of agarose (Fig. 2C), but not following
transfer from gel containing 1.2% agarose (data not
shown).
(ii). The US5-1 RNA is dependent on viral DNA synthe-
sis for its accumulation. In contrast, the OriS1 RNA does
not require de novo viral protein or DNA synthesis for its
accumulation [10]. The measured half-life (80 min.) is in
the line with that of other HSV-1 RNAs reported to be
between 60 and 150 minutes regardless of the kinetic
group to which a gene belongs [11].
(iii). In principle, viruses evolve continuously and do
not retain DNA sequences that have no functions related
to their survival in nature. The function of US5-1 RNA is
not known. The US5-1 RNA contains only two large ORFs
of 300+ codons. An ORF of approximately the same size
is present in the corresponding sequences of HSV-2
DNA. However, In HSV-1 DNA the first large ORF initi-
ates with the fifth methionine codon and its predicted
amino acid sequences is not conserved in the corre-
sponding HSV-2 ORF. We cannot exclude the possibility
that the very small ORFs upstream of the large one are
expressed. It seems it would be very unlikely that an RNA
4.5 kb long would encode a peptide with less than 100
amino acids, as it would be highly energy inefficient.
However, it would not be unprecedented, since Droso-
phila's tal gene expresses 1.5 kb long transcript that codes
for several 11 amino acid long peptides [12]. Overall, the
data do not currently support the hypothesis that the
US5-1 directs protein synthesis.
Figure 2 A RNA antisense to US3 accumulates in cells infected 
with wild-type virus. (A) Cultures of RSC in 25 cm2 flasks were mock 
infected (lanes 1 and 2) or infected with 10 PFU of HSV-1(F) (lanes 3 and 
4) or R7802 (lanes 5 and 6) per cell. Total RNA was extracted 18 h later 
and reverse transcription was performed on 1 μg of total RNA. As a 
control, 1 μg of RNA was subjected to the same treatment, except that 
reverse transcriptase was omitted (lanes 1, 3, and 5). (B) Cultures of RSC 
in 25 cm2 flasks were either mock infected (lane 1) or infected with 10 
PFU of HSV-1(F) (lane 2) or R7802 (lane 3) per cell. Total RNA was ex-
tracted 18 h later and aliquots of 10 μg of total RNA were separated on 
1% formaldehyde agarose gel, transferred to Biodyne B nylon mem-
brane and hybridized with single-stranded RNA probe 2. For the size 
determination molecular weight marker positions are shown. The 
amount of 18S ribosomal RNA is shown as the loading control.
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(iv) As noted earlier, the accumulation of HSV-1 non
coding RNAs is not unprecedented. There is considerable
current interest in non coding RNAs inasmuch as they
frequently serve as precursors of microRNAs or directly
regulate the expression of genes located antisense to the
RNA. We should note however that none of the studies
published to date reported microRNA derived from the
domain of the US5-1 RNA.
Conclusion
I n  t h i s  r e p o r t  w e  i d e n t i f i e d  a  n o v e l  H S V - 1  t r a n s c r i p t ,
expressed from the unique-short region of the viral
genome. It spans the region from the US5 to the α22
genes and is transcribed antisense to US5, US4, US3 and
α22 mRNAs, with γ2 kinetics. Our data suggest that US5-
1 is a long non-coding RNA. The role of this transcript is
currently unknown, but it is plausible that, similarly to
other long non-coding RNAs, it is involved in the regula-
tion of expression of viral genes.
Methods
Cells and viruses
Rabbit skin cells (RSC) were originally obtained from J.
McClaren. The cells were maintained in Dulbecco's mod-
ified Eagle's medium (DMEM) supplemented with 5%
fetal bovine serum. HSV-1(F) is the prototype HSV-1
strain used in the laboratory [13]. Mutant virus R7802,
which has the deletion of the entire ICP22 ORF has been
described elsewhere [14].
Northern blot
Cultures of RSC in 25-cm2  flasks were either mock
infected or infected with 10 PFU of virus per cell and
maintained at 37°C in medium 199 V consisting of a mix-
ture of 199 supplemented with 1% calf serum. The cells
Figure 3 The US5-1 RNA spans genomic region between US5 and ICP22. Cultures of RSC in 25 cm2 flasks were infected with 10 PFU of HSV-1(F) 
and total RNA was extracted 18 h after infection. The 3'- and 5'-ends were determined by RNase protection assay. In addition to samples from infected 
cells (panel A, lane 3 and panel B, lane 4), included were control samples of the equivalent amount of yeast total RNA, untreated (panel A, lane 2 and 
panel B, lane 2) or treated with RNAseA/RNaseT1 mix (panel A, lane 4 and panel B, lane 3). Single-stranded RNA marker was included for size determi-
nation (panels A and B, lane 1).
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were harvested at time points after infection specified for
each experiment. In some experiments cells were infected
in the presence of 100 μg/ml cycloheximide or 300 μg/ml
phosphonoacetate (PAA). Total RNA was extracted by
using Trizol reagent (Invitrogen, Carlsbad, CA). Aliquots
of 10 μg of total RNA were separated on 1,2%, 1% or 0.7%
formaldehyde agarose gels, transferred to Biodyne B
nylon membranes (Thermo Science, Rockford, IL) and
hybridized with single-stranded RNA probe transcribed
in vitro and labeled with biotin using MAXIscript kit
(Ambion, Austin, TX) from DNA template driven under
the T7 promoter. DNA template was generated by PCR
from the HSV-1 genomic DNA. Primers used for the gen-
eration of the DNA template were the following:
Probe 2(F): TAATACGACTCACTATAGGCATATAC-
TAGCGCGGATGCCGCGGAC
Probe 2(R): CATGCCAGTCACCAGCTTGGCCATG-
GTCGA
PCR reaction was performed using Pfu DNA poly-
merase (Stratagene, La Jolla, CA) under the following
conditions: 2 min. at 94°C followed by 30 cycles of 30 s at
94°C, 30 s at 60°C, 1 min at 68°C, with final 7 min at 68°C.
Figure 4 Kinetics and stability of US5-1 RNA. (A) Cultures of RSC in 25 cm2 were mock infected (lane 1) or infected with 10 PFU of HSV-1(F) per cell 
and total RNA was extracted 1 (lane 2), 3 (lane 3), 6 (lane 4) or 9 h (lane 5) after infection and analyzes for the expression of US5-1 by northern blot using 
0.7% formaldehyde agarose gel. The 28S ribosomal RNA is shown as the loading control. (B) Cultures of RSC in 25 cm2 flasks were mock infected (lane 
1) or infected with 10 PFU of HSV-1(F) per cell in the absence (lane 2) or presence (lane 3) of 100 μg/ml cycloheximide. Total RNA was extracted 9 h 
after infection and analyzed for the expression of US5-1 by northern using 0.7% formaldehyde agarose gel. The 28S ribosomal RNA is shown as the 
loading control. (C) Cultures of RSC in 25 cm2 flasks were mock infected (lane 1) or infected with 10 PFU of HSV-1 (F) per cell in the absence (lane 2) or 
presence (lane 3) of 300 μg/ml of phosphonoacetate (PAA). Total RNA was extracted 9 h after infection and analyzed for the expression of US5-1 by 
northern blot using 0.7% formaldehyde agarose gel. The 28S ribosomal RNA is shown as the loading control. (D) Cultures of RSC in 25 cm2 flasks were 
mock infected (lane 1) or infected with 10 PFU of HSV-1(F) per cell. At 6 h after infection actinomycin D (Act. D) was added to the concentration of 100 
μg/ml of medium. RNA was extracted 0 (lane 2), 1 (lane 3), 2 (lane 4), 3 (lane 5) or 4 h (lane 6) after the addition of Act. D and analyzed for the expression 
of US5-1 by northern blot using 0.7% formaldehyde agarose gel. The 28S ribosomal RNA is shown as the loading control. (E) The amount of the US5-1 
transcript in each experimental group in panel D was determined by measuring the density of each band on the membrane by UN-SCAN-IT densi-
tometer (Silk Scientific, Inc., Orhem, UT). Relative amount of US5-1 transcript, expressed as the percent of the US5-1 transcript at time zero, was plotted 
as the function of time.
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The location of the probe 2 within the unique-short
region of the HSV-1 genome and the direction of its tran-
scription is shown in figure 1C.
RNase Protection assay
RNA samples were prepared as described for northern
blot experiments. RNase protection assay was performed
using RPA III kit (Ambion, Austin, TX) according to
manufacturer's instructions. Briefly, aliquots of 10 μg of
total RNA were mixed with 2 × 104 cpm of probe labeled
with 32P-UTP using MAXIscript protocol (Ambion, Aus-
tin, TX) according to manufacturer's instructions and
precipitated. RNA samples were dissolved in hybridiza-
tion buffer, incubated at 56°C over night and treated with
RNaseA/RnaseT1 mix (1:150 dilution) for 30 minutes.
RNA was precipitated, dissolved in loading buffer, sepa-
rated on 5% acrylamide/8 M urea gel and exposed to
Kodak blue-bio autoradiography film (Denville Scientific,
Metuchen, NJ). DNA templates from which the probe 1
for identification of the 3'-end or probe 3 for identifica-
tion of the 5'-end of the US5-1 RNA were transcribed
were generated by PCR from the HSV-1 genomic DNA
using primers for probe 1:
P1(F): TAATACGACTCACTATAG-
GCATATACTTTCTGTGTGTCGCGATGT
P1(R): AGTTTGTACACGGATTTCCTGGTTAG
and for probe 3:
P3(F): TAATACGACTCACTATAGGCATATACAT-
GTCGGCGGAATCCACC
P3(R): AGTTTGTAATTGATACACTGGCGCAT for
probe 3
For the PCR reactions Pfu DNA polymerase was used
(Stratagene, La Jolla, CA) under the following conditions:
2 min. at 94°C followed by 30 cycles of 30 s at 94°C, 30 s at
60°C, 1 min at 68°C, with final 7 min at 68°C. The location
of the probe 1 and probe 3 within the unique-short region
of the HSV-1 genome and the direction of their transcrip-
tion is shown in figure 1C.
Reverse-transcription PCR
RNA samples were prepared as described for northern
blot experiments. Reverse transcription was performed
on 1 μg of total RNA using Reverse Transcription System
(Promega, Madison, WI) according to manufacturer's
instructions. Primer used for reverse transcription was
51(R): ATGTACGGAAACCAGGACTACC. As a control,
the same amount of RNA was subjected to the same
treatment, except that reverse transcriptase was omitted.
For PCR amplification the following primers were used:
51(R) and 51(F): TCCCGGCTGCGTCGTCGTATAC
All PCR reactions were performed using Pfu DNA
polymerase (Stratagene, La Jolla, CA) under the following
conditions: 2 min. at 94°C followed by 30 cycles of 30 s at
94°C, 30 s at 60°C, 1 min at 72°C, with final 7 min at 72°C.
PCR products were separated on 1% agarose gel and visu-
alized by ethidium-bromide staining. The location of
primers used for RT-PCR within the unique-short region
of the HSV-1 genome is shown in figure 1C.
Half-life studies
Cultures of RSC in 25-cm2  flasks were either mock
infected or infected with 10 PFU of virus per cell and 6 h
after infection actinomycin D (AcD) was added to the
concentration of 100 μg/ml. RNA was extracted 1, 2, 3 or
4 h after the addition of AcD as processed for northern
blot analysis. The intensity of the bands on the film was
measured by UN-SCAN-IT densitometer (Silk Scientific,
Inc., Orhem, UT) and relative amount calculated as the
percentage of RNA present at the time of the addition of
AcD was plotted as the function of time.
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